annual cash & cash equivalents:
$448.03M-$62.98M(-12.32%)Summary
- As of today (September 14, 2025), MLTX annual cash & cash equivalents is $448.03 million, with the most recent change of -$62.98 million (-12.32%) on December 31, 2024.
- During the last 3 years, MLTX annual cash & cash equivalents has risen by +$439.99 million (+5473.31%).
- MLTX annual cash & cash equivalents is now -12.32% below its all-time high of $511.01 million, reached on December 31, 2023.
Performance
MLTX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$425.08M-$55.05M(-11.47%)Summary
- As of today (September 14, 2025), MLTX quarterly cash & cash equivalents is $425.08 million, with the most recent change of -$55.05 million (-11.47%) on June 30, 2025.
- Over the past year, MLTX quarterly cash & cash equivalents has dropped by -$94.72 million (-18.22%).
- MLTX quarterly cash & cash equivalents is now -22.30% below its all-time high of $547.05 million, reached on March 31, 2024.
Performance
MLTX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MLTX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.3% | -18.2% |
| 3 y3 years | +5473.3% | +358.5% |
| 5 y5 years | +10000.0% | +100.0% |
MLTX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.3% | +5473.3% | -22.3% | +574.2% |
| 5 y | 5-year | -12.3% | >+9999.0% | -22.3% | >+9999.0% |
| alltime | all time | -12.3% | >+9999.0% | -22.3% | >+9999.0% |
MLTX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $425.08M(-11.5%) |
| Mar 2025 | - | $480.13M(+7.2%) |
| Dec 2024 | $448.03M(-12.3%) | $448.03M(-9.3%) |
| Sep 2024 | - | $493.92M(-5.0%) |
| Jun 2024 | - | $519.80M(-5.0%) |
| Mar 2024 | - | $547.05M(+7.1%) |
| Dec 2023 | $511.01M(+608.6%) | $511.01M(+3.0%) |
| Sep 2023 | - | $495.98M(-1.2%) |
| Jun 2023 | - | $501.79M(+695.9%) |
| Mar 2023 | - | $63.05M(-12.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $72.11M(+797.1%) | $72.11M(-13.6%) |
| Sep 2022 | - | $83.46M(-10.0%) |
| Jun 2022 | - | $92.71M(-8.2%) |
| Mar 2022 | - | $101.02M(+1156.7%) |
| Dec 2021 | $8.04M(+501.8%) | $8.04M(+681.4%) |
| Sep 2021 | - | $1.03M(-6.3%) |
| Jun 2021 | - | $1.10M(-6.2%) |
| Mar 2021 | - | $1.17M(-12.4%) |
| Dec 2020 | $1.34M | $1.34M(>+9900.0%) |
| Sep 2020 | - | $0.00 |
FAQ
- What is MoonLake Immunotherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual cash & cash equivalents year-on-year change?
- What is MoonLake Immunotherapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly cash & cash equivalents year-on-year change?
What is MoonLake Immunotherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of MLTX is $448.03M
What is the all time high annual cash & cash equivalents for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual cash & cash equivalents is $511.01M
What is MoonLake Immunotherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, MLTX annual cash & cash equivalents has changed by -$62.98M (-12.32%)
What is MoonLake Immunotherapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MLTX is $425.08M
What is the all time high quarterly cash & cash equivalents for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly cash & cash equivalents is $547.05M
What is MoonLake Immunotherapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, MLTX quarterly cash & cash equivalents has changed by -$94.72M (-18.22%)